Uniphar PLC (LSE: UPR) Targets Group EBITDA of €200mn Over Medium-Term

2 min read | March 14, 2024 04:53 PM AEDT | By Team Kalkine

Google News:

Uniphar PLC (LSE: UPR) Targets Group EBITDA of €200mn Over Medium-Term — Image source: Explode, Shutterstock.com

Recent News

Can Firming Capacity Spark The Next ASX Energy Move?

ASX 200 Energy Stocks Hit A Margin Crossroad

ASX 200 Income Debate Heats Up Before EOFY

Viking Mines (ASX:VKA) Advances Linka Tungsten Project with Positive O...

Make Kalkine Media
My Trusted Source

Highlights

Uniphar achieved ~23.3% year-on-year growth in revenue in FY23, with over 17% YoY increase in its EBITDA.

UPR’s operating profit has increased to €67.71 million with 27.4% YoY growth in FY23.

In FY24, UPR aims to achieve a double-digit growth in gross profit for its Pharma division.

FTSE AIM 100 index listed Uniphar PLC (LSE:UPR) is a diversified healthcare services business serving over 200 multinational pharmaceutical and medical technology companies.

For the full fiscal year 2023, Uniphar achieved approximately 23.3% year-on-year growth in its revenue. It recorded over 17% YoY increase in its EBITDA in FY23. Also, UPR’s operating profit has increased to €67.71 million with 27.4% YoY growth in FY23.

There has been 5.2% YoY surge in total dividend payment per share for the full year. It has announced to pay an interim dividend of 1.19 euro cents per share in May 2024, with an ex-dividend date of 18 April 2024.

In FY24, UPR aims to achieve a double-digit growth in gross profit for its Pharma division. It is anticipating a high single-digit organic gross profit increase for its Medtech division in FY24.

The company expects improvement in the market leadership position in Supply Chain & Retail division following strategic investment in a new distribution facility as well as acquisition of McCauley. Notably, UPR is looking forward to make a €60 million investment in an IT and ERP investment programme. With the acquisition of BModesto and Orspec in its Product Access division, the firm will have a broader foothold in Europe and the APAC region. The prime objective is to grow its Group EBITDA to €200 million over the medium-term.

Top 10 Shareholders:

Around 44.96% of the total shareholding in the company is held by its top ten shareholders. While Allianz Global Investors GmbH is the biggest shareholder in the firm with 12.04% shareholding, Polar Capital LLP is the second biggest shareholder with approximately 7.37% shareholding.

Stock Price Performance

UPR’s stock price has dropped 2.88% in the last one month. It has gained over 7.27% over the last six months. The stock’s 52-week low and high price stand at GBX 178.00 and GBX 300.00, respectively.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 13 March 2024. The reference data in this report has been partly sourced from EODHD/Others.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.